UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 815

Sortiert nach

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

Rheumatology (Oxford, England), 2003-02, Vol.42 (2), p.244-257

2003

Link zum Volltext

Verfügbarkeit prüfen

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.823-827

2009

Link zum Volltext

Verfügbarkeit prüfen

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide

Annals of the Rheumatic Diseases, 2002-04, Vol.61 (4), p.290-297

2002

Link zum Volltext

Verfügbarkeit prüfen

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1373-1378

2006

Link zum Volltext

Verfügbarkeit prüfen

80 milestones in rheumatology from 80 years. II. 1961-1980

Zeitschrift für Rheumatologie, 2021-08, Vol.80 (6), p.506-514

2021

Link zum Volltext

Verfügbarkeit prüfen

Autoantibody profiles in the sera of European patients with myositis

Annals of the rheumatic diseases, 2001-02, Vol.60 (2), p.116-123

2001

Link zum Volltext

Verfügbarkeit prüfen

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2002-12, Vol.61 (12), p.1065-1070

2002

Link zum Volltext

Verfügbarkeit prüfen

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

Annals of the rheumatic diseases, 2004-09, Vol.63 (9), p.1172-1176

2004

Link zum Volltext

Verfügbarkeit prüfen

Infliximab in active early rheumatoid arthritis

Annals of the rheumatic diseases, 2004-02, Vol.63 (2), p.149-155

2004

Link zum Volltext

Verfügbarkeit prüfen

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

Annals of the rheumatic diseases, 2005-11, Vol.64 (suppl 4), p.iv2-iv14

2005

Link zum Volltext

Verfügbarkeit prüfen

Biologics

Zeitschrift für Rheumatologie, 2016-08, Vol.75 (6), p.604-610

Kalden, J R

2016

Link zum Volltext

Verfügbarkeit prüfen

Appropriate and effective management of rheumatoid arthritis

Annals of the Rheumatic Diseases, 2004-06, Vol.63 (6), p.627-633

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1168-1177

2003

Link zum Volltext

Verfügbarkeit prüfen

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

Annals of the rheumatic diseases, 2006-11, Vol.65 (suppl 3), p.iii2-iii15

2006

Link zum Volltext

Verfügbarkeit prüfen

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

The Lancet (British edition), 1994-10, Vol.344 (8930), p.1105-1110

1994

Link zum Volltext

Verfügbarkeit prüfen

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine

Annals of the rheumatic diseases, 2001-10, Vol.60 (10), p.913-923

2001

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with coronary artery calcification in young female patients with SLE

Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.846-850

2003

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

Annals of the rheumatic diseases, 2001-11, Vol.60 (suppl 3), p.iii55-iii57

2001

Link zum Volltext

Verfügbarkeit prüfen

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)

Annals of the rheumatic diseases, 2002-11, Vol.61 (suppl 2), p.ii2-ii7

2002

Link zum Volltext

Verfügbarkeit prüfen

Distinct tumour necrosis factor α, interferon γ, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener’s granulomatosis

Annals of the rheumatic diseases, 2005-03, Vol.64 (3), p.457-461

2005

Link zum Volltext

Verfügbarkeit prüfen

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

Annals of the rheumatic diseases, 2003-11, Vol.62 (suppl 2), p.ii2-ii9

2003

Link zum Volltext

Verfügbarkeit prüfen

IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera

Annals of the rheumatic diseases, 2008-11, Vol.67 (11), p.1626-1632

2008

Link zum Volltext

Verfügbarkeit prüfen

Advances in targeted therapies X

Annals of the rheumatic diseases, 2008-12, Vol.67 (Suppl 3), p.iii1-iii1

2008

Link zum Volltext

Verfügbarkeit prüfen

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

Annals of the rheumatic diseases, 2003-01, Vol.62 (1), p.81-82

2003

Link zum Volltext

Verfügbarkeit prüfen

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012

Annals of the Rheumatic Diseases, 2013-04, Vol.72 (suppl 2), p.ii2

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 815

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(607)
Mit Volltextzugriff
(594)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(627)
Deutsch
(187)
Japanisch
(43)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(505)
Science & Technology
(386)
Life Sciences & Biomedicine
(381)
Biological And Medical Sciences
(234)
Medical Sciences
(199)
Rheumatology
(189)
Female
(175)
Male
(156)
Immunology
(144)
Adult
(138)
Middle Aged
(136)
Animals
(90)
Rheumatoid Arthritis
(86)
Aged
(74)
Diseases Of The Osteoarticular System
(70)
Arthritis, Rheumatoid - Immunology
(69)
Antirheumatic Agents - Therapeutic Use
(65)
Antibodies, Monoclonal - Therapeutic Use
(61)
Arthritis, Rheumatoid - Drug Therapy
(60)
T-Lymphocytes - Immunology
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

80 milestones in rheumatology from 80 years. II. 1961-1980

Autoantibody profiles in the sera of European patients with myositis

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

Infliximab in active early rheumatoid arthritis

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

Biologics

Appropriate and effective management of rheumatoid arthritis

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine

Factors associated with coronary artery calcification in young female patients with SLE

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)

Distinct tumour necrosis factor α, interferon γ, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener’s granulomatosis

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera

Advances in targeted therapies X

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012

Suchergebnisse filtern